Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets
GR-2021-12373041
Approved small_molecule active
Quick answer
Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets for patients with secondary progressive MS is a Approved program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Verona Pharma Ireland Limited
- Indication
- patients with secondary progressive MS
- Phase
- Approved
- Modality
- small_molecule
- Status
- active